10 ways to optimise patient access through the product life cycle with Managed Access Programmes
Pharmaceutical Marketing Europe, March 2013

Perspective on Wall Street Journal article describing one woman's journey to gain access
Suzanne Gagnon, MD
Chief Medical Officer, Idis

Real World Insights - Commercial teams as well as patients can benefit from managed access programs
Sue Barrowcliffe, Idis
Pharmaceutical Executive, November 2012

Successful importation of cytarabine into the United States during a critical national drug shortage
Dee Hunnisett-Dritz, Park Nicollet Methodist Hospital, St. Louis Park, Minnesota
American Journal of Health-System Pharmacy, August 2012

Providing access now
John Lagus and Kelly Fearn, Idis
Pharmaceutical Executive, April 2012

Contrasting approaches to early access across the globe
Heather Manna, Idis
Pharmafocus, December 2010 

Why provide early market access?
Simon Estcourt, Idis
European Pharmaceutical Contractor, December 2010

Need for speed. Accelerating access to drugs for orphan diseases
Simon Estcourt, Idis
Pharmaceutical Marketing Europe, Sept/Oct 2010

Managing access to drugs prior to approval and launch
Simon Estcourt, Idis
Life Science Leader, May 2010

Named patient programs provide pre-launch access to drugs
Jack Talley, EpiCept
PharmaVoice, May 2010